NDC 42292-017-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-017
- Requested NDC
- 42292-017-01
- Package NDCs from labels
- 42292-017-01, 42292-017-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Mylan Institutional Inc. | Mylan Institutional Inc. | 2025-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42292-017-01 | Spironolactone and Hydrochlorothiazide | 1 in 1 BLISTER PACK | TABLET | 1 | 9 | |
| 42292-017-20 | Spironolactone and Hydrochlorothiazide | 100 in 1 CARTON | TABLET | 100 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-017-01 | EA - Each | 42292-017 | 8cd108e4-b464-4100-9b08-87c109e4ea12 | 1 | 2017-08-11 |
| 42292-017-20 | EA - Each | 42292-017 | 0113bb4e-b99c-4b82-b696-2531c5d9ad2c | 1 | 2017-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.